Booster shot recommendations still unclear, says acting FDA commissioner
There is still uncertainty and questions to be answered regarding whether all Americans will be recommended to receive booster shots of the COVID-19 vaccine, said acting U.S. Food and Drug Administration Commissioner Dr. Janet Woodcock.
Woodcock spoke with former senior White House COVID-19 response adviser Andy Slavitt on his podcast program “The Bubble” on Monday, raising questions on what the booster shots may or may not do and discussing any uncertainties that could have factored into the FDA’s decision to recommend boosters only for high-risk Americans and those over the age of 65.
Right now, the FDA does not know enough about how an additional shot will impact transmissibility or about cellular immunity and whether T-cells are protected, among other factors, Woodcock said.
“Basically the FDA decision is, do the overall benefits outweigh the potential harms for any given vaccination and that’s how to proceed,” Woodcock said. “But obviously individuals benefit from not having a transmissible virus circulating around."
-ABC News’ Matthew Vann